Swiss dental startup vVardis shares slide 7% in NYSE debut as tech selloff roils IPO market
vVardis had sold 9.7 million shares at $18 apiece in its IPO, well below its targeted range of $21 to $24 per share.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
